옵션 체인은 다양한 행사가격과 만기일에 대한 Repare Therapeutics의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Repare Therapeutics에 대한 시장 심리를 평가합니다..

Repare Therapeutics (NASDAQ:RPTX) 주식, 옵션 체인

REPARE THERAPEUTICS INC

Repare Therapeutics

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Cathie Wood Bets On Baidu As Chinese AI Buzz Intensifies, Ark Loads Up On $12.4 Million Worth Of Stock

Equities

News

Markets

ARKG

ARKK

PATH

PRME

RPTX

2025년 4월 11일 금요일, 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 유아이패스(NYSE:PATH), 프라임 메디슨(NGM:PRME) 및 리페어 테라퓨틱스(NASDAQ:RPTX)의 주식을 매도하는 주목할 만한 거래를 실행했다.

캐시 우드의 아크 인베스트, 유아이패스, 프라임 메디슨 그리고 리페어 테라퓨틱스를 매도

Tech

ETFs

AMZN

ARKF

ARKQ

ARKW

BEAM

COIN

CRSP

MELI

RBLX

2025년 4월 4일 금요일에 캐시 우드가 이끄는 아크 인베스트는 코인베이스 글로벌(NASDAQ:COIN), 아마존닷컴(NASDAQ:AMZN), 크리스퍼 테라퓨틱스 AG(NGM:CRSP), 빔 테라퓨틱스(NASDAQ:BEAM), 유아이패스(NYSE:PATH), 로블록스(NYSE:RBLX), 메르카도리브레(NASDAQ:MELI), 그리고 리페어 테라퓨틱스(NASDAQ:RPTX)를 포함한 여러 저명한 기업에 대해 상당한 거래를 했다.

아크 인베스트, 아마존 주식이 20% 이상 하락한 가운데 매수: 유아이패스, 로블록스 매각

Cathie Wood Defies CoreWeave IPO Slump, Ark Snaps Up $3.6 Million Worth Of Stock In Nvidia-Backed Company

GTLB

HOOD

목요일(3일) 캐시 우드가 이끄는 아크 인베스트는 로빈후드 마켓츠(NASDAQ:HOOD)의 주식을 매입하며 의미 있는 행보를 보였다. 이번 전략적 투자는 로빈후드가 플랫폼을 지속적으로 확장하고 금융 서비스 제공을 강화하면서 이루어졌다.

아크 인베스트, 관세로 인한 매도세 속 로빈후드 주식 139만 달러 상당 매입

Repare Therapeutics Inc

<ul>
<li>Updated interim results with an additional ~16 weeks of follow-up on nine patients in Cohort 1 (2.5 mCi) and Cohort 2 (5.0 mCi) and initial safety findings in an additional 33 patients treated in Cohort 2 from the ongoing Phase 1/2a study were presented</li>
<li>[212Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities and no discontinuations due to adverse events observed among a total of 42 patients who received at least one treatment</li>
<li>Four of seven patients in Cohort 2 experienced investigator-assessed objective responses as defined by RECIST v1.1. Three of those patients experienced confirmed response and remained in response. One new first response is subject to confirmation.</li>
<li>Seven of nine patients in Cohorts 1 and 2 remained free from disease progression after more than one year of follow-up</li>
<li>Perspective will hold a conference call on Monday, June 2, 2025 at 8:00 am ET &nbsp;</li>
</ul>

Biotech

General

CATX

Perspective Therapeutics Reveals New Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET At The 2025 ASCO Annual Meeting

LION

Liberty 77 Capital Reports 12.6% Stake In Lionsgate Studios As Of May 28 Vs Prior Stake Of 9.5% As Of May 6

CTXR

Citius Pharmaceuticals Not In Compliance With Nasdaq Minimum Bid Price

CoStar Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>), a leading provider of online real estate marketplaces, information, analytics and 3D digital twin technology in the property markets, announced today that CoStar Group and Happening Technology have concluded their dispute, with all parties withdrawing every claim with prejudice, bringing the matter to a final and amicable close.
Guy Wolcott, a serial entrepreneur, founded the successful residential real estate platform Homesnap in 2012, which CoStar Group acquired in 2020 for $250 million. At the time of the acquisition, Homesnap was used regularly by over 300,000 residential agents in the United States. After departing CoStar, Wolcott, Thomas Goff, and Jeff Repanich launched Happening Technology to develop an innovative data pipeline product, with former Homesnap CEO John Mazur later becoming an investor and board member. Similarities between this product and CoStar's internal data pipeline technology prompted CoStar's reasonable concern regarding potential trade secret misappropriation — concerns that have now been fully addressed. Following a thorough review, the parties concluded that neither Happening Technology nor Wolcott, Goff, Repanich, or Mazur misappropriated CoStar's trade secrets or violated any other legal obligation.
CoStar Group and Happening Technology are pleased to put this matter behind them and are open to exploring potential opportunities for collaboration in the future.

Legal

CSGP

CoStar Group And Happening Technology Resolve Trade Secret Dispute Amicably With All Claims Withdrawn; No Misappropriation Found As Parties Close Case And Express Openness To Future Collaboration

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 20 years by 7.9% on an annualized basis producing an average annual return of 16.18%. Currently, W.W. Grainger has a market capitalization of $52.39 billion. 
Buying $100 In GWW: If an investor had bought $100 of GWW stock 20 years ago, it would be worth $2,014.00 today based on a price of $1087.60 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748639712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In W.W. Grainger 20 Years Ago Would Be Worth Today

<h2 class="wp-block-heading">Zinger Points:</h2>
<ul class="wp-block-list">
<li>Crusoe secures $11.6 billion to build OpenAI's massive 1.2 gigawatt Abilene, Texas data center, part of the $500 billion Project Stargate.</li>
<li>Oracle has signed a 15-year lease to anchor the Abilene data center.</li>
<li>Crusoe's evolution from gas-powered crypto rigs to liquid-cooled AI supercenters captures the arc of next-gen computing.</li>
</ul>
AI infrastructure startup Crusoe Energy Systems has secured $11.6 billion in funding commitments to build a massive data center in Abilene, Texas, designed to support OpenAI's expanding computing needs. The new funding round, backed by Blue Owl Capital's Real Assets platform and Primary Digital Infrastructure, brings total capital raised for the project to $15 billion, The <a href="https://www.wsj.com/tech/ai/openai-data-center-funding-microsoft-75e879b6">Wall Street Journal </a>reported.
<h2 class="wp-block-heading">Abilene: The Heart of OpenAI&#8217;s Infrastructure Expansion</h2>
According to <a href="https://crusoe.ai/newsroom/crusoe-expands-ai-data-center-campus-in-abilene-to-1-2-gigawatts/">Crusoe</a>, the facility marks a critical step in OpenAI's infrastructure strategy. Initially planned as a two-building campus, the project now spans eight buildings. It is expected to deliver 1.2 gigawatts of power capacity, making it one of the largest AI training hubs globally.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
According to the company, construction began last June, with the first two buildings—totaling 200 megawatts—expected to be energized in the first half of this year. A second phase, launched in March, will add six more buildings and is expected to be completed by mid-2026.
<h2 class="wp-block-heading">Oracle Steps In as Microsoft's Footprint Shrinks</h2>
The expansion comes amid growing demand for compute capacity as OpenAI develops increasingly advanced artificial intelligence models. Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has signed a 15-year lease to occupy a significant portion of the Abilene campus, according to the Journal.&nbsp;
While Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) remains OpenAI's largest investor and retains exclusive application programming interface licensing rights, its role in the Abilene project is limited to that of a technology partner, without direct equity involvement. OpenAI has increasingly sought to diversify its infrastructure partnerships, citing concerns over Microsoft's ability to scale fast enough to meet its compute needs, the Journal reported.
Meanwhile, JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has committed over $7 billion to the data center project, building on a previous $2.3 billion investment, according to <a href="https://www.theinformation.com/articles/jpmorgan-lend-7-billion-openai-data-center">The Information</a>.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Project Stargate: A $500B Vision For AI Infrastructure</h2>
The Abilene project is part of &#8220;Project Stargate,&#8221; a $500 billion global AI infrastructure initiative launched in January by OpenAI, Oracle, SoftBank, and United Arab Emirates-based MGX, <a href="https://www.forbes.com/sites/emilsayegh/2025/01/22/stargate-ai-project-the-500-billion-gamble-to-dominate-the-future/">Forbes</a> reported. The project aims to build a vast network of AI data centers over the next four years to support rapid model development and increase U.S. leadership in artificial intelligence.
According to <a href="https://crusoe.ai/newsroom/crusoe-blue-owl-capital-and-primary-digital-infrastructure-enter-joint-venture">Crusoe</a>, the buildings planned in Abilene are designed for industry-scale performance, with each capable of running up to 50,000 GB200 NVL72 chips from Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) on a unified network fabric.
<h2 class="wp-block-heading">Economic and Environmental Considerations</h2>
Beyond scale, the Abilene campus is also a model for energy-conscious AI infrastructure. It incorporates direct-to-chip liquid cooling to manage thermal loads and partners with Lancium's Clean Campus program to integrate renewable energy sources, <a href="https://crusoe.ai/newsroom/crusoe-expands-ai-data-center-campus-in-abilene-to-1-2-gigawatts/">Crusoe</a> said. Crusoe expects the project to create over 5,000 jobs and generate more than $1 billion in local economic impact over the next two decades.
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">Crusoe's Strategic Shift</h2>
Founded in 2018, Denver-based Crusoe began as a company converting stranded natural gas into energy for crypto mining. In recent years, it has repositioned itself as a vertically integrated AI infrastructure provider, with a sharp focus on sustainable, high-density compute environments, according to <a href="https://news.crunchbase.com/ai/startup-crusoe-financing-openai-data-center-texas/">Crunchbase</a>.
The <a href="https://www.benzinga.com/24/12/42476730/peter-thiels-founders-fund-leads-600m-crusoe-investment-betting-big-on-ai-infrastructure">company raised $600 million</a> in Series D funding led by Founders Fund, with participation from Fidelity and Nvidia, bringing its valuation to $2.8 billion. The Abilene project represents Crusoe's most ambitious venture to date and positions it at the center of the rapidly expanding AI infrastructure race.
Read Next: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
Image: Shutterstock

Personal Finance

MSFT

NVDA

ORCL

OpenAI Secures $11.6B For Texas Data Center Expansion, Reducing Microsoft Dependence

A recent Reddit post from a frustrated husband in the r/Dave Ramsey <a href="https://www.reddit.com/r/DaveRamsey/comments/1kt761y/can_someone_confirm_my_wifes_spending_is/">subreddit</a> caught people&#8217;s attention after asking if his wife's spending habits were out of line. His main complaint? Over the last 90 days, the family spent $6,769 on dining out alone.
&#8220;Luckily we are positive net worth,&#8221; he wrote. &#8220;But she is delaying our retirement saying her spending is normal for having 2 kids. I cover probably 80-90% of essentials from my side.&#8221;
According to his breakdown, they also spent $1,330 on groceries during the same period, along with $1,230 on supplies, $1,250 on healthcare, $560 on gas, and $1,200 on other expenses.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Reddit Reacts: &#8216;That&#8217;s Almost $30K a Year&#8217;</h2>
The response was swift and nearly unanimous. One commenter was particularly direct: &#8220;Dining out isn't just delusional, <a href="https://www.benzinga.com/personal-finance/25/02/43602320/70-year-old-with-0-saved-for-retirement-still-works-physically-demanding-job-dave-ramsey-says-eating-out-is-causing-you-to-clean-toilets">it's irresponsible</a> and incredibly selfish. That's almost $30k a year.&#8221; They also pointed out that if they placed that money with a financial advisor, &#8220;at $2k a month, and they earned an average of 12%, you have almost $650k in 15 years.&#8221;
Another person added their own math of how much they could get over 30 years if they invested that money: &#8220;$6769 was for 3 months, so $27k/year. Turns into $3 mil in 30 years at 8%.&#8221;
Others were comparing themselves: &#8220;We make $380k a year and eat out about $500/month. That dining out number is terrifying.&#8221;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">&#8216;Stop Saying &#8220;I Cover Most of the Bills&#8221;&#8216;</h2>
While many were focused on the spending itself, others pushed the husband to reconsider how he approached the issue.
&#8220;Stop saying ‘I cover most of the bills&#8230;' you are we,&#8221; one person said, pointing to the importance of shared financial responsibility in a marriage, something Dave Ramsey often <a href="https://www.benzinga.com/personal-finance/25/02/43768530/should-married-couples-split-expenses-dave-ramsey-says-no-youre-married-not-roommates">teaches and preaches</a>.
Another chimed in with, &#8220;This reads more like a marriage issue than a money issue. Does she handle all of the child rearing and housework? Get off the spreadsheet and be the partner your wife needs and communicate through this issue.&#8221;
Still, others called for practical changes instead of blame. &#8220;Cut dining out to a quarter of that and add 1-2 grand to groceries and cook more – problem solved.&#8221;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Context Matters</h2>
Many asked for more context, like income and lifestyle. Some speculated that the high numbers may be inflated by convenience apps like DoorDash. The original poster later clarified that his wife eats out &#8220;2x a day at nice restaurants always with extra appetiser or entree with some meal for kids.&#8221;
Another commenter couldn't believe it: &#8220;That is not normal. Eating out is luxury, a treat. Eating out twice a day is not normal. She is choosing eating out over your future.&#8221;
Others shared how they made it work. &#8220;We make $240k a year and it was our New Year's resolution to eat out once a month,&#8221; one user wrote. &#8220;We spend maybe $100/month eating out and that&#8217;s because we&#8217;re trying.&#8221;
In the end, what this comes down to is that the spending problem the poster has isn't just about dollars and cents. &#8220;Delusional is not a word to use if you want to have a happy marriage,&#8221; one person advised. &#8220;Some work to be done on spending and discussing spending.&#8221;
Read Next:
<ul class="wp-block-list">
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

A Husband Asks, 'Can Someone Confirm My Wife's Spending Is Delusional?' He Points To $6,769 Spent On Dining Out In Just 90 Days

Management

RETO

On May 25, ReTo Eco-Solutions Hengfang Li Tendered Resignation As CEO And Director; Co. Appointed Xinyang Li To Serve As CEO

Asset Sales

APLD

Applied Digital Discussing Possible Sale Of Cloud Services Business; Cloud Services Business To Be Reported As Discontinued Operations

BBLG

Bone Biologics Approves Plan Amendment To Increase Shares By 30M

Offerings

ADAG

Adagene Files For Offering Of Up To $100M American Depositary Shares Representing Ordinary Shares

SBET

SharpLink Gaming Announces Private Placement Offering Of ~58.7M Shares Of Common Stock And Pre-Funded Warrants At $6.15 Per Share; CEO and CFO Participate With $200K Combined Investment

<h3>Gainers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock increased by 6.8% to $0.48 during Friday's after-market session. The company's market cap stands at $9.6 million. </li>
<li>Venu Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VENU#AMEX">VENU</a>) shares moved upwards by 6.55% to $9.98. The market value of their outstanding shares is at $378.3 million. </li>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATBP#NASDAQ">FATBP</a>) stock rose 5.8% to $2.37. </li>
<li>GEN Restaurant Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) shares moved upwards by 4.84% to $3.46. The market value of their outstanding shares is at $17.4 million. </li>
<li>Fossil Group, Inc. - 7% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSLL#NASDAQ">FOSLL</a>) stock increased by 4.59% to $16.61. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) stock increased by 4.38% to $0.51. The market value of their outstanding shares is at $12.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ContextLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGC#NASDAQ">LOGC</a>) stock decreased by 17.3% to $6.78 during Friday's after-market session. The market value of their outstanding shares is at $180.9 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) shares declined by 8.67% to $4.11. The company's market cap stands at $836.6 million. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares declined by 7.7% to $1.32. The market value of their outstanding shares is at $39.8 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares declined by 5.5% to $2.75. The company's market cap stands at $12.5 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares decreased by 4.84% to $73.0. The company's market cap stands at $50.9 million. </li>
<li>High Roller Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ROLR#AMEX">ROLR</a>) stock fell 4.82% to $4.15. The market value of their outstanding shares is at $34.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMST

FATBP

FLYE

Fossil Group, Inc. - 7% Senior Notes due 2026

FOSLL

FTEL

GENK

LOGC

LVWR

ROLR

TLYS

VENU

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares rose 32.5% to $0.38 during Friday's after-market session. The market value of their outstanding shares is at $2.2 million. As per the press release, Q1 earnings came out today. </li>
<li>Kymera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) shares rose 15.99% to $34.38. The market value of their outstanding shares is at $2.2 billion. </li>
<li>Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) stock moved upwards by 10.52% to $16.49. The company's market cap stands at $1.4 billion. </li>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) shares moved upwards by 10.16% to $0.66. The market value of their outstanding shares is at $106.8 million. </li>
<li>Rafael Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RFL#NYSE">RFL</a>) stock rose 8.38% to $1.55. The market value of their outstanding shares is at $57.7 million. </li>
<li>Biote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTMD#NASDAQ">BTMD</a>) shares increased by 8.37% to $3.75. The market value of their outstanding shares is at $118.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) stock declined by 29.6% to $0.01 during Friday's after-market session. The market value of their outstanding shares is at $4.6 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock fell 15.69% to $4.14. The market value of their outstanding shares is at $3.0 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares decreased by 11.63% to $0.38. The market value of their outstanding shares is at $1.8 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares fell 10.53% to $5.44. The market value of their outstanding shares is at $102.1 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares declined by 8.74% to $0.94. The company's market cap stands at $8.1 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 8.44% to $0.44. The market value of their outstanding shares is at $8.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMGL

BTMD

ENTO

INTS

IRWD

KYMR

LGMK

LQDA

PSTV

RSLS

SLXN

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>JFB Construction (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFB#NASDAQ">JFB</a>) shares rose 17.0% to $6.55 during Friday's after-market session. The market value of their outstanding shares is at $60.5 million. </li>
<li>Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) shares moved upwards by 6.53% to $0.88. The market value of their outstanding shares is at $137.3 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares moved upwards by 5.44% to $0.32. The company's market cap stands at $8.4 million. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) shares rose 5.12% to $3.49. The market value of their outstanding shares is at $45.3 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares moved upwards by 5.0% to $0.49. The company's market cap stands at $15.4 million. </li>
<li>TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) shares increased by 4.99% to $6.3. The company's market cap stands at $187.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) stock decreased by 8.4% to $1.64 during Friday's after-market session. The market value of their outstanding shares is at $84.1 million. </li>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares declined by 7.65% to $4.71. The market value of their outstanding shares is at $62.9 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock declined by 6.16% to $0.37. The company's market cap stands at $6.6 million. </li>
<li>Eve Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVEX#NYSE">EVEX</a>) shares decreased by 5.56% to $5.1. The company's market cap stands at $1.5 billion. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares decreased by 5.17% to $3.12. The company's market cap stands at $8.4 million. </li>
<li>NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) shares decreased by 5.17% to $2.02. The market value of their outstanding shares is at $157.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EVEX

HTOO

ILAG

NPWR

NRGV

OFAL

ONEG

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) stock rose 77.2% to $0.49 during Friday's after-market session. The market value of their outstanding shares is at $20.4 million. </li>
<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) shares increased by 11.76% to $1.14. The market value of their outstanding shares is at $9.3 million. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares increased by 5.0% to $0.67. The company's market cap stands at $35.9 million. </li>
<li>Thumzup Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) stock moved upwards by 4.98% to $8.63. The company's market cap stands at $82.0 million. </li>
<li>WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) stock moved upwards by 4.78% to $1.09. The market value of their outstanding shares is at $114.4 million. </li>
<li>Maris Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEK#NASDAQ">MTEK</a>) shares rose 4.62% to $2.26. The company's market cap stands at $17.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock declined by 9.2% to $1.09 during Friday's after-market session. The market value of their outstanding shares is at $79.0 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock fell 4.49% to $2.98. The market value of their outstanding shares is at $4.5 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) stock fell 4.42% to $0.65. The market value of their outstanding shares is at $5.8 million. </li>
<li>BIO-key International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) stock fell 3.58% to $0.81. The company's market cap stands at $4.7 million. </li>
<li>Interlink Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINK#NASDAQ">LINK</a>) shares declined by 3.26% to $6.25. The market value of their outstanding shares is at $61.6 million. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock decreased by 3.01% to $0.91. The market value of their outstanding shares is at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASNS

BKYI

BNAI

GRYP

IFBD

LINK

MAPS

MOBX

MTEK

PRSO

SOBR

TZUP

12 Information Technology Stocks Moving In Friday's After-Market Session

OAKU

Oak Woods Acquisition Receives Nasdaq Deficiency Letter Regarding Delayed Filing of Quarterly Report on Form 10-Q

In the current market session, Antero Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) stock price is at $37.45, after a 3.58% decrease. However, over the past month, the company's stock went up by 4.73%, and in the past year, by 6.66%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1748638872_0.png" alt="Past Year Chart" />

<h3>Evaluating Antero Resources P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Antero Resources has a better P/E ratio of 50.44 than the aggregate P/E ratio of 17.75 of the Oil, Gas &amp; Consumable Fuels industry. Ideally, one might believe that Antero Resources Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748638872_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Antero Resources Inc's Price Over Earnings

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has outperformed the market over the past 5 years by 7.84% on an annualized basis producing an average annual return of 21.69%. Currently, JPMorgan Chase has a market capitalization of $733.68 billion. 
Buying $1000 In JPM: If an investor had bought $1000 of JPM stock 5 years ago, it would be worth $2,677.48 today based on a price of $264.00 for JPM at the time of writing.
<h3>JPMorgan Chase's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748638817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

IVDA

Iveda Solutions Receives Non-Compliance Notice From Nasdaq

Press Releases

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Opinion

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Repare Therapeutics Announces Leadership Transitions

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics

Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates

Comments

Repare Therapeutics

Repare Therapeutics (RPTX) 옵션

Repare Therapeutics (NASDAQ:RPTX) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌